Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
US Department of Justice
Daiichi Sankyo
Chubb
Deloitte
Citi
Fuji
Merck

Generated: April 26, 2018

DrugPatentWatch Database Preview

gamma-Aminobutyric Acid A Receptor Agonist Drug Class List

« Back to Dashboard

Drugs in Drug Class: gamma-Aminobutyric Acid A Receptor Agonist

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer SONATA zaleplon CAPSULE;ORAL 020859-001 Aug 13, 1999 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer SONATA zaleplon CAPSULE;ORAL 020859-002 Aug 13, 1999 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int ZALEPLON zaleplon CAPSULE;ORAL 077237-001 Jun 6, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Unichem ZALEPLON zaleplon CAPSULE;ORAL 078989-001 Jun 6, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Colorcon
Argus Health
Johnson and Johnson
Chubb
Harvard Business School
Dow
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.